MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Medicenna Therapeutics Corp.
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Ownership
Who owns Medicenna Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Healthcare Fund, L.P. | 7,714,760 | 9.99% | 13G (passive) | Apr 30, 2024 |
| Orin Hirschman | 4,672,075 | 6.70% | 13G (passive) amendment | Dec 31, 2023 |
| Rosemina Merchant | 20,244,255 | 29.10% | 13G (passive) amendment | Dec 31, 2023 |